Japan Life Insurance announced that it would spend $8.2 billion to acquire the life insurance company Resolution Life. On December 11th, Japan Life Insurance Mutual announced that it would spend about $8.2 billion to acquire the remaining 77% shares of the life insurance company Resolution Life. The transaction is expected to be completed in the second half of 2025. On the same day, Japan Life announced that it would acquire the remaining 20% shares of MLC Life Insurance from National Bank of Australia (NAB) and integrate MLC with Resolution Life.Israeli military: In the past 48 hours, it has attacked Syria's "most strategic weapons reserves". The Israel Defense Forces said on the 11th that in the past 48 hours, the Israeli army has attacked Syria's "most strategic weapons reserves". According to Israeli media reports, the Israeli army has destroyed "70% to 80% of the strategic military capability of the Assad regime".Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.
President of Japan Life Insurance: In a growing market, Resolution Life is an excellent company, so we hope to ensure its potential together. Note: Japan Life Insurance announced on December 11th that it will spend about US$ 8.2 billion to acquire the remaining 77% shares of Resolution Life.Palestinian health department: 60 wounded people in a hospital in northern Gaza are facing death danger. The Palestinian health department announced on the 11th local time that 60 wounded people in Indonesian hospital in northern Gaza are facing death danger due to lack of food and water, and the humanitarian situation in the hospital has become extremely critical. The department called on all parties concerned and humanitarian organizations to intervene immediately and provide necessary assistance.China Minerals and Guangxi Iron and Steel have established mining technology companies. The enterprise search APP shows that recently, China National Mining Chain (Guangxi) Mining Technology Co., Ltd. was established, with Ji Wendong as the legal representative and a registered capital of 90 million yuan. Its business scope includes mineral washing and processing, metal ore sales and metal material sales. Enterprise survey shows that the company is jointly owned by China Mineral's China Mineral Resources Group International Supply Chain Co., Ltd. and Guangxi Iron and Steel Group Co., Ltd.
Boeing also exposed nearly 1,000 layoffs. According to Xinhua News Agency, citing American media reports, American aircraft manufacturer Boeing will lay off employees again, involving nearly 1,000 people in Washington State and California. This batch of layoffs is part of Boeing's plan to lay off 17,000 people worldwide announced in October.Can TCL make a three-fold mobile phone? Li Dongsheng responded: We have the technology, depending on the needs of the market. At the TCL Global Technology Innovation Conference held today, Li Dongsheng, the founder and chairman of TCL, attended the conference for the 11th time and made a live speech. At this conference, TCL exhibited and introduced the first Tandem three-fold screen (7.85 ") developed by the company. The folding screen can support "G-shaped" or "Z-shaped" folding, and combines Tandem, LTPO and PLP multiple low-power technologies to realize comprehensive promotion of high brightness, low power consumption and long service life. Will TCL launch three-fold mobile phones and other products? In the communication with Sina Technology, Li Dongsheng responded that "we have such technology", but we need to "see the market needs" whether to launch related products. (Sina Technology)Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.
Strategy guide
12-13
Strategy guide
12-13
Strategy guide
12-13
Strategy guide
12-13